\-\ Texto\\:\\ \ \(0\)\
\-\ bilateral\\ lower\\ extremity\\ weakness\\ and\\ decreased\\ sensation\\.\ \(0\)\
\-\ surgical\\ resection\\.\ \(23\)\
\-\ hypointense\\ \\(relative\\ to\\ cord\\,\\ t1\\)\\ filum\\ terminale\\ mass\\ lesion\\ occupying\\ the\\ entire\\ central\\ canal\\.\\ \\ heterogenous\\ appearing\\ on\\ t2\\,\\ ranging\\ from\\ iso\\-\\ to\\ slightly\\ hyperintense\\ \\(relative\\ to\\ cord\\)\\.\\ \\ strong\\ but\\ slightly\\ heterogenous\\ enhancement\\.\ \(0\)\
\-\ filum\\ terminale\\ myxopapillary\\ ependymoma\ \(0\)\
\-\ schwannoma\ \(67\)\
\-\ meningioma\ \(167\)\
\-\ paragaglioma\ \(0\)\
\-\ drop\\ mets\ \(2\)\
\-\ 16\\ year\\ old\\ male\\ with\\ bilaterally\\ symmetrical\\ low\\ back\\ pain\\ progressing\\ to\\ weakness\\ and\\ decreased\\ sensation\\ in\\ lower\\ extremities\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ filum\\:\\ 0\\.3325023786242777\ \(0\)\
\-\ terminale\\:\\ 0\\.3325023786242777\ \(0\)\
\-\ heterogenous\\:\\ 0\\.24370466557491824\ \(0\)\
\-\ relative\\:\\ 0\\.22921202797348006\ \(0\)\
\-\ sensation\\:\\ 0\\.22172448120538052\ \(0\)\
\-\ paragaglioma\\:\\ 0\\.20688573956381467\ \(0\)\
\-\ slightly\\:\\ 0\\.20182528729505303\ \(0\)\
\-\ cord\\:\\ 0\\.19178899112796266\ \(0\)\
\-\ weakness\\:\\ 0\\.18882986708275895\ \(0\)\
\-\ myxopapillary\\:\\ 0\\.16822448329019488\ \(0\)\
\-\ decreased\\:\\ 0\\.1602649524075512\ \(0\)\
\-\ ranging\\:\\ 0\\.15466639244891608\ \(0\)\
\-\ progressing\\:\\ 0\\.14960581484073904\ \(0\)\
\-\ symmetrical\\:\\ 0\\.14623986072697018\ \(0\)\
\-\ occupying\\:\\ 0\\.1407148592241517\ \(0\)\
\-\ drop\\:\\ 0\\.1407148592241517\ \(0\)\
\-\ strong\\:\\ 0\\.1348120096409911\ \(0\)\
\-\ mets\\:\\ 0\\.13299675514779633\ \(0\)\
\-\ lower\\:\\ 0\\.13221319261294742\ \(0\)\
\-\ to\\:\\ 0\\.12936582301374494\ \(0\)\
\-\ entire\\:\\ 0\\.117717539815108\ \(0\)\
\-\ hypointense\\:\\ 0\\.1138436371810012\ \(0\)\
\-\ schwannoma\\:\\ 0\\.11086224060269026\ \(0\)\
\-\ ependymoma\\:\\ 0\\.10927567955300396\ \(0\)\
\-\ appearing\\:\\ 0\\.10337282996984339\ \(0\)\
\-\ hyperintense\\:\\ 0\\.10290521393299093\ \(0\)\
\-\ 16\\:\\ 0\\.10080691583691602\ \(0\)\
\-\ canal\\:\\ 0\\.09957519735094433\ \(0\)\
\-\ extremities\\:\\ 0\\.09831225236166637\ \(0\)\
\-\ meningioma\\:\\ 0\\.0969373723713571\ \(0\)\
\-\ extremity\\:\\ 0\\.09317620521861582\ \(0\)\
\-\ central\\:\\ 0\\.08638980299377139\ \(0\)\
\-\ bilaterally\\:\\ 0\\.08627836014396029\ \(0\)\
\-\ back\\:\\ 0\\.08627836014396029\ \(0\)\
\-\ resection\\:\\ 0\\.08292582700704709\ \(0\)\
\-\ t1\\:\\ 0\\.08060362500398136\ \(0\)\
\-\ enhancement\\:\\ 0\\.07446130079692574\ \(0\)\
\-\ t2\\:\\ 0\\.07442831377394535\ \(0\)\
\-\ low\\:\\ 0\\.07423139293350198\ \(0\)\
\-\ bilateral\\:\\ 0\\.06952651329717782\ \(0\)\
\-\ but\\:\\ 0\\.06397210427418563\ \(0\)\
\-\ surgical\\:\\ 0\\.06287650393370299\ \(0\)\
\-\ lesion\\:\\ 0\\.06202134069161742\ \(0\)\
\-\ male\\:\\ 0\\.05759909345485444\ \(0\)\
\-\ and\\:\\ 0\\.053464147090286476\ \(0\)\
\-\ from\\:\\ 0\\.05137902405524693\ \(0\)\
\-\ mass\\:\\ 0\\.04941467920231874\ \(0\)\
\-\ pain\\:\\ 0\\.04629221603383012\ \(0\)\
\-\ year\\:\\ 0\\.039868312910822795\ \(0\)\
\-\ on\\:\\ 0\\.039071006067745405\ \(0\)\
\-\ old\\:\\ 0\\.03828738115339154\ \(0\)\
\-\ in\\:\\ 0\\.03218227117519928\ \(0\)\
\-\ the\\:\\ 0\\.025813372039950475\ \(0\)\
\-\ with\\:\\ 0\\.025331644493816436\ \(0\)\
